Sangart

About:

Sangart is a biopharmaceutical company developing global scientific, clinical and commercial oxygen-therapeutic agents.

Top Investors: Jefferies Financial Group, ODIN Forvaltning

Description:

Sangart, Inc. is a privately held biopharmaceutical company focused on being the global scientific, clinical and commercial leader in oxygen-therapeutic agents, providing innovative products to patients in need. Sangart was founded in 1998 based on discoveries arising from over two decades of research in red blood cell substitutes and the mechanisms of oxygen transport by cell-free hemoglobin solutions.

Total Funding Amount:

$294M

Headquarters Location:

San Diego, California, United States

Founded Date:

1998-01-01

Founders:

Number of Employees:

51-100

Last Funding Date:

2012-05-24

IPO Status:

Private

Industries: